Cargando…
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model
The large use of target therapies in the treatment of gastrointestinal stromal tumors (GISTs) highlighted the urgency to integrate new molecular imaging technologies, to develop new criteria for tumor response evaluation and to reach a more comprehensive definition of the molecular target. These asp...
Autores principales: | Pantaleo, M. A., Landuzzi, L., Nicoletti, G., Nanni, C., Boschi, S., Piazzi, G., Santini, D., Di Battista, M., Castellucci, P., Lodi, F., Fanti, S., Lollini, P.-L., Biasco, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709232/ https://www.ncbi.nlm.nih.gov/pubmed/19225718 http://dx.doi.org/10.1007/s10238-009-0033-5 |
Ejemplares similares
-
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET
por: Pantaleo, Maria Abbondanza, et al.
Publicado: (2010) -
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET
por: Pantaleo, Maria A., et al.
Publicado: (2010) -
Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.
por: Nicoletti, G., et al.
Publicado: (1992) -
Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.
por: Nanni, P., et al.
Publicado: (1992) -
Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
por: De Giovanni, C., et al.
Publicado: (1993)